These miRNAs are thought to target important cell cycle genes such as CDK6 [150], RAS p21 protein activator 1 (RASA1) [151], or KRAS gene [152] to promote cell proliferation, migration, and invasion in CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.